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Amyotrophic lateral sclerosis (ALS) is a devastating neurode-
generative disease characterized by the selective and progressive
loss of upper and lower motor neurons (MNs) of the brain-
stem, spinal cord and cerebral cortex. Key discoveries in the field
of ALS have exponentially increased since it was first described
in 1869 by Jean Martin Charcot, and the identification in 1993
of the first ALS-causing mutations in the gene encoding the
well-studied antioxidant enzyme Cu, Zn superoxide dismutase
(SOD1). The etiology of sporadic ALS largely remains unknown
and the mechanisms of MN degeneration are still being investi-
gated. The only FDA drug approved for the treatment of ALS,
riluzole only modestly benefits patients, but multiple drugs are
currently in the development pipeline and in human ALS clini-
cal trials. It has become obvious that the lack of understanding of
the precise mechanisms of motor neuron degeneration presents a
major obstacle in the development of effective therapies for ALS.
Altered calcium homeostasis and calcium signaling pathway acti-
vation is one potential mechanism that accounts for at least three
major and interrelated toxic pathways: oxidative stress, mitochon-
drial dysfunction and neuroinflammation in neurodegenerative
diseases such as ALS.
The aim of this special topic was to determine the role of cel-
lular Ca2+ homeostasis and mitochondrial signaling pathways in
selectively vulnerable MNs in ALS. In fact, recent evidence sug-
gests that abnormalities in cellular Ca2+ signaling are common
features in the pathogenesis of a range of neurodegenerative dis-
orders, including ALS. It is well known that Ca2+ is one of the
most relevant intracellular messengers, being essential in neu-
ronal development, synaptic transmission and plasticity, as well
as in the regulation of various metabolic pathways in the brain
level. In subtypes of ALS associated with the SOD1 mutation and
the sporadic disease, there have been several reports indicating
that the involvement of mitochondria in pathogenesis includes
the generation of intracellular free radical species, ultrastruc-
tral changes in mitochondrial morphology, swollen and vacuolar
mitochondria and increased activity of complex I, III and IV in
the Upper and lower MNS, frontal cortex and spinal cord (von
Lewinski and Keller, 2005). Impaired spinal cord and vulnerable
individual spinal MNs have also been reported. It has been pro-
posed that this damage triggers the functional decline of MNs
and the onset of pathology in ALS. The loss of mitochondrial
membrane potential, excitotoxic stimulation of AMPA/kainite
receptors and age related MN injury reported by many groups
may contribute to ALS pathogenesis.
Further evidence for the involvement of disruption of intra-
cellular Ca2+ homeostasis arises from several studies of cellular
and experimental animal models of ALS in which Ca2+ binding
proteins such as calbindin-D28K and parvalbumin in MN popu-
lations are lost early (hypoglossal, spinal, and lower cranial MNs).
These findings are in good agreement with a quantitative com-
parison of Ca2+ homeostasis where low cytosolic Ca2+ buffering
capacity acts as an important risk factor for degeneration and in
contrast an increase in cytosolic Ca2+ buffering capacity could
protect vulnerable MNs from degeneration both in-vitro and in-
vivo. Several lines of evidence support altered Ca2+ homeostasis
leading to MN degeneration in ALS, notably disturbance of glu-
tamate neurotransmission and subsequent glutamate triggered
Ca2+ entry, increased extracellular glutamate levels probably due
to reduced glial glutamate uptake caused by oxidative damage
to EAAT2, study of fALS in cell lines and animal mouse mod-
els where potential mechanism for Ca2+disruption is inhibition
of glial glutamate transport by mSOD1 similar to those proposed
for sALS. Evidence also suggests that ROS generated in MNs can
cross the plasma membrane and cause oxidative disruption of
glutamate transporters in neighbouring astrocytes. However, in
ALS pathology, the nature of dysfunction is highly controversial
after recent findings where non-cell autonomous effect of glia on
MNs in an embryonic stem cell-based ALS model and astrocytes
expressing ALS-linked mSOD1 that release factors selectively
toxic to MNs was shown. The data currently available so far leave
several important questions unanswered; these include: (1) does
the presence of mSOD1 cause morphological abnormalities of
mitochondria when expressed at physiological levels? (2) Does
the mitochondrial Ca2+ sequestration source specificity and spa-
tiotemporal properties of [Ca2+]i signaling varies at physiological
levels? (3) What are the functional consequences of any changes
in mitochondrial function on Ca2+ homeostasis in the presence
of mutant SOD1 gene?
Combining the lessons from multiple animal models as well
as cell culture model used to determine pathogenic mecha-
nisms in ALS, the central insight is that selective vulnerability
of MNs likely arises from a combination of several mechanisms;
two of them, mitochondrial dysfunction and Ca2+ homeosta-
sis are prominent (Jaiswal and Keller, 2009; Jaiswal et al., 2009).
Documenting the involvement and importance of mitochondrial
dysfunction and Ca2+ homeostasis we believe that MN possess
large number of voltage and ligand gated Ca2+ channels that,
when activated, cause rapid Ca2+ influx, which, in part because
Frontiers in Cellular Neuroscience www.frontiersin.org October 2013 | Volume 7 | Article 199 | 1
CELLULAR NEUROSCIENCE
Jaiswal Calcium, mitochondria, and the pathogenesis of ALS
of relatively weak cytosolic Ca2+ buffering, results in mitochon-
drial Ca2+ overload and strong ROS generation. Alternatively,
the extrusion mechanisms, characterized by the plasma mem-
brane calcium ATPase, Na+/Ca2+ exchanger and accumulation
by intracellular organelles contribute to the removal of calcium
ions. Furthermore, their selective loss goes a long way explaining
the oxidative damage, mitochondrial abnormalities and apop-
totic contributions observed in ALSMNs. Chronic mitochondrial
membrane depolarisation due to Ca2+ entry can cause the release
of pro-apoptotic proteins and activate enzymes involved in apop-
totic pathways.
In the last few years, attention was drawn to the role of
mitochondria as an efficient regulator of cytosolic calcium sig-
nals. Further studies with mitochondria targeted calcium probes
indicate a rapid, dramatic increase in free intramitochondrial cal-
cium. This uptake by mitochondria has an immense effect on
the metabolic state of the cell as it can up regulate the activ-
ity of the enzymes in oxidative metabolism. The malformations
in mitochondrial structure and massive vacuoles derived from
degenerating mitochondria found in post mortem human ALS
samples further strengthen the proposition. Although the exact
molecular mechanism is still not known, we hypothesize that
vulnerability to ALS is a consequence of specific physiological
features, particularly highly specialized Ca2+ homeostasis, con-
tinuous activity-dependent Ca2+cycling and the predominant
role of mitochondria in buffering Ca2+ transients. Definitive evi-
dence for this will have to wait for further studies. Nevertheless,
if Ca2+ homeostasis and mitochondrial defects were found to
play a role in disease pathogenesis, this would have broad ranging
implications for therapy. Further studies will therefore be of con-
siderable interest in attempting to understand the pathogenesis of
cell death in ALS.
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